Definitive Contract 75A50122C00033
Award Date
6/29/22
Potential Completion Date
6/29/24
Potential Value
$749K
Ultimate Awardee
State Of California Controllers Office
PSC Category
AN15 - Health R&D Services; Health Care Services; Expenses For R&D Facilities And Major Equipment
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90095, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, has awarded a $749,937 firm fixed-price contract to the University of California, Los Angeles (UCLA) to conduct research and development for the Ferrobotic Multiplexed Diagnostic Platform (FMDX) for at-home monitoring under Announcement of Opportunity #16 (AOI #16) - Lab at Home. This definitive contract has a period of performance ending on March 25, 2025 and does not...
<p>The University of California, Los Angeles, doing business as the Office of Research Administration, was awarded a $749,507 definitive contract by the Centers for Disease Control and Prevention to extend the SwabSeq agnostic diagnostic platform. The contract has a start date of September 29, 2023 and end date of September 28, 2025, and utilizes a firm fixed price structure. Performance will take place in Los Angeles, California. No subcontractors were identified.</p>
This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to the University of California, Los Angeles (UCLA), acting through its Office of Research Administration division. The contract is for biomedical (applied/exploratory) research services, with a potential value of $825,342.00 and a completion date of December 31, 2004. The contract is a definitive contract with a cost no fee pricing type and...
This is a $6,203,491.79 firm fixed price definitive contract awarded by the National Heart Lung and Blood Institute, part of the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA) for the RADX TECH PROJECT NO. 2320 - SWABSEQ effort. The contract has no set-aside designation and is scheduled for completion by August 31, 2022. As the prime contractor, UCLA's Office of Research Administration will leverage the university's expertise, facilities, and...
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a division of the U.S. Department of Health and Human Services (HHS), to the University of California, Los Angeles (UCLA) Office of Research Administration. The contract has a ceiling value of $100,000.00 and a completion date of December 28, 2017. There was no set-aside designation for this award. As a prime contractor, UCLA will provide research, training, and program...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a Firm Fixed Price Purchase Order contract worth $49,874 by the Smithsonian Institution to provide assistance on the "ONE HEALTH PROTECT PROJECT" with a performance period ending on December 31, 2024. This contract has no set-aside designation. As a public research university and one of the largest employers in California, UCLA leverages its facilities, faculty expertise, and...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a definitive contract by the U.S. government to provide research and development (R&D) services. The contract, with a potential value of $1,736,000.00, was awarded on September 30, 1997, and has a completion date of August 31, 2003. The contract is a cost-no-fee type and does not have a set-aside designation, indicating that it was competitively awarded. As a prime contractor, UCLA is...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $265,649.00 firm fixed price purchase order to the University of California, Los Angeles (UCLA) to provide data files, syntax files, code books, metadata, and reports related to the UCLA COVID-19 Health Project. This award has a completion date of May 1, 2023 and was made on April 2, 2021. The contract does not have a set-aside designation. UCLA's Office of Research Administration, which supports the...
This federal contract award is for a definitive contract with a potential value of $1,330,915.00 between the University of California, Los Angeles (UCLA) and an unspecified government agency. UCLA, through its Office of Research Administration, is providing research, training, and program implementation services as the prime contractor. The contract does not have a set-aside designation. UCLA is leveraging its facilities, faculty expertise, administrative capabilities, and partnerships to...
This is a $48,051,765.59 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA) to provide biomedical research and related services. The contract has no set-aside designation and was awarded on September 22, 1994 with a completion date of June 20, 2014. As the prime contractor, UCLA's Office of Research Administration is leveraging the university's...